Association of Coffee Consumption With Peri-Implant Status
ACCPS
1 other identifier
observational
291
1 country
1
Brief Summary
A total of 123 participants (291 implants) applying to Bolu Abant İzzet Baysal University will be included in the study. Based on anamnesis, radiographic examination, and the 2018 classification of periodontal diseases, the participants will be categorized into three groups: peri-implant health (n = 97 implants), peri-implant mucositis (n = 97 implants), and peri-implantitis (n = 97 implants). Information regarding participants' coffee consumption habits and their daily coffee intake will be collected. Clinical parameters to be measured will include plaque index, gingival index, bleeding on probing, gingival recession, and clinical attachment level. The frequency of coffee consumption will be evaluated as daily, 1-2 times per week, 3-4 times per week, once per month, twice per month, and once per year. The amount of coffee consumed at a single occasion (cup, glass, mug, etc.) will also be recorded. In caffeinated coffee consumption, the preference for weak, moderate, or strong coffee, as well as consumption with milk, condensed milk, sugar, honey, or sweeteners will be assessed. For Turkish coffee, the consumption pattern will be categorized as unsweetened, moderately sweetened, or sweetened.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
CompletedFirst Submitted
Initial submission to the registry
July 31, 2026
CompletedFirst Posted
Study publicly available on registry
August 5, 2026
CompletedAugust 5, 2026
July 1, 2026
1.5 years
July 31, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of consumption of coffee
The frequency of fermented foods is measured. The foods questioned were evaluated using a 7-point Likert-type frequency form (every day, 3-4 per week, 1-2 per week, 2 per month, 1 per month, never). In addition, the amounts of foods consumed each time were recorded, and the daily consumption amounts were obtained by dividing them by the frequency of consumption.
Baseline
Secondary Outcomes (6)
probing depth
Baseline
bleeding on probing
Baseline
plaque index
Baseline
gingival index
Baseline
clinical attachment level
Baseline
- +1 more secondary outcomes
Study Arms (3)
Peri-implantitis
Peri-implantitis patients are those who have developed inflammation around a dental implant, leading to the loss of supporting bone and the presence of pockets of infection.
Peri-implant mucositis
Peri-implant mucositis refers to a reversible inflammatory condition affecting the soft tissues surrounding a dental implant, characterized by redness, swelling, and bleeding on probing, without any bone loss.
Peri-implant health
Peri-implant health refers to the condition where the tissues surrounding a dental implant are free from inflammation, with no signs of redness, swelling, bleeding on probing, or bone loss, indicating a stable and healthy implant environment.
Interventions
The type of coffee consumed, the daily amount of coffee, and the frequency of consumption were measured.
Eligibility Criteria
Patients who have received implants
You may qualify if:
- Being between 18 and 45 years of age.
- Having one or more fixed prosthesis-supported dental implants, with at least one year and no more than five years having passed since the functional prosthetic loading of the dental implant(s).
You may not qualify if:
- Having smoked more than 100 cigarettes during their lifetime.
- Being an active smoker.
- Having uncontrolled diabetes mellitus.
- Use of antibiotics or anti-inflammatory medications.
- Pregnant or breastfeeding women.
- Patients who received treatment for peri-implant disease after implant placement.
- Presence of residual cement remnants.
- Having malpositioned implants.
- Receiving active periodontal treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tuğba ŞAHİNlead
Study Sites (1)
Bolu Abant İzzet Baysal University
Bolu, Bolu, 14030, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TUGBA SAHIN
Abant Izzet Baysal University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
July 31, 2026
First Posted
August 5, 2026
Study Start
December 7, 2024
Primary Completion
May 30, 2026
Study Completion
May 30, 2026
Last Updated
August 5, 2026
Record last verified: 2026-07